Contributor Page
Hogan Lovells
 
Email  |  Website  |  Articles
Contact Details
Tel: +32 2 505 0911
Fax: +32 2 505 0996
Pericles Building
Rue de la Science 23
Brussels
1040
Belgium
Awards
Contributor Most Read
Contributor Most Read
Contributor Most Read
Contributor Most Read
Contributor Most Read
Most Reader Response
Most Reader Response
Most Reader Response
Most Reader Response
Most Reader Response
Most Reader Response
Most Reader Response
Most Reader Response
Most Reader Response
Most Popular Article
Most Popular Article
Most Popular Article
By Louise Lamb, Daniela Vella, Tom Devine
The English High Court has given effect to the terms of a loan agreement relieving a financial institution of the obligation to make interest payments,..
By Hogan Lovells
The Bank of England (BoE) has published the high level findings of the financial sector cyber simulation exercise that took place on 9 November 2018 (SIMEX 18).
By Wouter Jongen
The LMA Early Evening Seminar at Hogan Lovells Amsterdam on 1 October 2019 explored some trends in the leveraged finance market, with reports of a very healthy Dutch market
By Simon Recher
The Directive on undertakings for collective investment in transferable securities ("UCITS") is 34 years old. The Directive on alternative investment funds managers ("AIFM")
By Julia Matheson, David Brzozowski
The USPTO has recently released its latest trademark fee proposal for 2020. The proposal includes substantial increases to many existing fees,...
By Hogan Lovells
The SEC's Division of Corporation Finance recently announced changes to its process for responding to no-action requests that seek exclusion from proxy materials of shareholder
By Jane Seager, Ying Lou
In a recent decision under the Uniform Domain Name Dispute Resolution Policy (UDRP) before the World Intellectual Property Organization (WIPO), a panel has denied the ...
By Yarmela Pavlovic, Lina R. Kontos, Kristin Zielinski Duggan, Tammi Tram Huynh
On 27 September 2019 the U.S. Food and Drug Administration (FDA or the agency) released a series of guidance documents addressing the agency's ...
By Stacy Hadeka, Rebecca H. Umhofer, Michael J. Scheimer, Jonathan Stulberg
Through ADG Insights, we share with you the top legal and political issues affecting the aerospace, defense, and government services (ADG) industry.
By Yarmela Pavlovic, Jennifer Agraz Henderson, Susan D. Tiedy-Stevenson, Lina R. Kontos, Suzanne Levy Friedman, Tammi Tram Huynh
On 27 September 2019 the U.S. Food and Drug Administration (FDA or the agency) released the draft guidance entitled "Clinical Decision Support Software" (CDS guidance), ...
By Hannah Quarterman
In the second of our series on compulsory purchase, we turn to what you should do if your property is at risk of compulsory acquisition.
By Stephanie Carman, Tziporah Tapp
Some high-level considerations regarding what a company could do before and when faced with a government investigation.
By Hogan Lovells
In Russia 2018 and 2019 have been interesting years for patentlitigation. A number of revolutionary rulings were made in favor...
By James Kwan, James Ng
According to an announcement made on the People's Court Daily, the Arrangement Concerning Mutual Assistance in Court-ordered Interim Measures in Aid of Arbitral Proceedings
By Tao Leung, Michelle Roberts Gonzales, Ashley King
On September 18, 2019, California Governor Gavin Newsom signed into law a bill that attempts to settle some of the ambiguity that remained surrounding ...
Contributor's Topics
More...